Table 1 The clinical characteristics of the patient who received allogeneic HSCT.
Characteristics of patient | Number of patients |
|---|---|
Number of patients | 176 |
AML | 104 (59.1%) |
ALL | 72 (40.9%) |
Male:female | 88:88 |
Age | |
AML | 30.64 ± 11.43 (range from 1 to 66 years old) |
ALL | 21.86 ± 14.12 (range from 0.8 to 54 years old) |
Survival rate | 52% |
Relapse rate | 74% |
GVHD | |
Non-GVHD | 19 |
Grade 1–2 | 97 |
Grade 3–4 | 48 |
Chronic | 12 |
CMV infection | 99 |
Source of cells | |
PB | 124 |
BM | 52 |
Conditioning regimen | |
Only chemotherapy | 104 |
Only radiotherapy | 11 |
Chemoradiotherapy | 55 |
NA | 6 |